Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Effectiveness and Safety of Generic vs Original Imipenem/cilastatin in Hospitalized Patients in Thailand
TCTR20210730004Completed
- Sponsor
- Siam Pharmaceutical
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of imipenem + cilastatin in bacterial disease (2 arms), sponsored by Siam Pharmaceutical. Primary endpoints: Therapeutic effectiveness non-inferiority and Safety outcomes. Started Nov 2017; status: completed.
02
Drugs
imipenem + cilastatin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on TCTR20210730004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210730004.